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Abstract CD98 is a multifunctional protein involved in amino
acid transport and regulation of integrin-mediated cell adhesion.
Herein, we demonstrated that CD98 stimulation by anti-CD98
antibodies induced CEA-CAM-1-mediated cell adhesion in
BaF3 cells expressing CEA-CAM-1, and suggest that this might
be responsible for compact clumping of F9 embryonic carcinoma
cells by CD98 stimulation. CEA-CAM-1 was co-immunopreci-
pitated by anti-CD98 antibody. CD98 stimulation induced the
translocation of cytoplasmic protein kinase CN (PKCN) to the
cell adhesion sites, and rottlerin that inhibited the PKCN trans-
location abolished the cell aggregation without a¡ecting integrin
activation. The results suggested that CD98 stimulation could
activate CEA-CAM-1-mediated cell adhesion independently of
integrins.
- 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
CD98 is a heterodimeric membrane protein consisting of a
heavy (H) chain and one of at least six alternative light (L)
chains [1]. Four of the L chains are shown to have L-type
amino acid transport activity [2], while a common H chain
plays a role in guiding the heterodimeric complex to the plas-
ma membrane [3]. CD98 is expressed in various normal cells
and most tumor cells [4]. In addition to the amino acid trans-
port activity, diverse functions have been ascribed to CD98,
such as regulation of cell adhesion, cell fusion, and prolifer-
ation [5]. Accumulating evidence indicates that CD98 plays a
signi¢cant role in regulating integrin-mediated cell adhesion
[6]. Cross-linking CD98 by anti-CD98 monoclonal antibodies
(mAbs) was shown to promote K3L1-integrin-dependent syn-
cytium formation associated with virus infection [7]. It was
reported that transfection of CD98 H chain cDNA could
reverse the dominant negative e¡ect of the chimeric cytoplas-
mic domain of L1 integrin, and that cross-linking CD98 en-
hanced L1-integrin-mediated cell adhesion [8]. Several reports
also indicated that CD98 was associated with L1-integrins [9^
11], and we reported that CD98 stimulation by anti-CD98
mAbs induced the activation of L2-integrin (LFA-1) via phos-
phatidylinositol 3-kinase (PI3K) and Rap1 activation [12].
Recently, Rintoul et al. reported that cross-linking CD98 in-
duced the clustering of L1-integrins and proposed that CD98
acted as a ‘molecular facilitator’ in the plasma membrane [13].
In the present study, we show that CD98 stimulation can
activate CEA-CAM-1-mediated cell adhesion via protein ki-
nase CN (PKCN) activation. The results reveal that CD98 can
regulate di¡erent types of adhesion molecules through distinct
mechanisms, reinforcing the notion that CD98 acts as a ‘mo-
lecular facilitator’ in the plasma membrane.
2. Materials and methods
2.1. Cells and culture
F9, EL and BaF/3 cell lines were maintained in 10% fetal calf
serum, Dulbecco’s modi¢ed Eagle’s medium and RPMI 1640, respec-
tively, with additional interleukin-3 (100 U/ml) for the latter. The
BaF/3 cell line transfected with human LFA-1 (B/LFA-1) has been
reported before [14].
2.2. Antibodies and reagents
Anti-mouse CD98 H chain (14.37, 10.10) and L chain (10.7) mAbs
as well as rabbit anti-mouse CEA-CAM-1 antibodies (#2456 and
#231) have been reported before [3,15]. In some experiments, the
F(abP)2 fragment of mAb 14.37 was used. Anti-PKCN antibody (Santa
Cruz), rottlerin (Sigma) and wortmannin (Sigma) were purchased
commercially.
2.3. cDNA transfection
BaF/3 cells were transfected with cDNA of CEA-CAM-1 long (L)
or short (S) isoform in a pLXSN vector by electroporation and se-
lected in medium containing 1.2 mg/ml G418 (B/C-CAM-1-L, B/C-
CAM-1-S).
2.4. Immunoprecipitation, immunoblotting and £ow cytometry
Cells were lysed with bu¡er (150 mM NaCl, 50 mM Tris^HCl pH
7.4, inhibitors of proteases and phosphatases) containing varying con-
centrations of NP-40. The lysates were incubated overnight with anti-
CD98 mAb at 4‡C followed by precipitation with protein A-Sephar-
ose beads. Immunoblotting and £ow cytometric analysis were done as
before [3,16].
2.5. Immunostaining
B/C-CAM-1 cells cultured in the presence of mAb 14.37 (2 Wg/ml)
were ¢xed by drop-wise addition of 2 volumes of 2U¢xing solution
(7.4% formaldehyde, 0.4% Triton X-100 in phosphate-bu¡ered saline).
After 10 min, the cells were cytospun gently and two-color-stained
with biotinylated mAb 10.10 and rhodamine^streptavidin followed
by rabbit anti-CEA-CAM-1 antibody and FITC-anti-rabbit IgG. F9
cells were cultured on coverslips in the absence or presence of mAb
14.37 and similarly immunostained. The samples were analyzed with a
confocal microscope (Olympus).
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3. Results
3.1. Anti-CD98 mAb induces Ca2+-independent cell clumping in
F9 embryonic carcinoma cells
F9 cells cultured in the presence of anti-CD98 H chain mAb
(14.37) for over 24 h formed highly compact cellular clumps
resembling embryonic bodies, while they normally grew in a
£at monolayer (Fig. 1, b vs. a). To examine the localization of
CD98, we immunostained the F9 cells with biotinylated mAb
10.10 recognizing a di¡erent epitope of CD98 H chain. While
CD98 was detected evenly around the entire cell surface in-
cluding the cell contact-free surface of control F9 cells, it was
localized exclusively at the cell^cell adhesion sites of those
cultured with mAb 14.37 (Fig. 1, c vs. d). The cell size of
the latter was smaller than that of the former, re£ecting the
tight three-dimensional packing of the cells. F9 cells cultured
with mAb 14.37 remained aggregated signi¢cantly after brief
treatment with trypsin/EDTA, while control F9 cells were
dispersed completely (Fig. 1, f vs. e). L cells expressing
E-cadherin (EL) showed no such clumping by mAb 14.37 in
spite of the comparable expression of CD98 (data not
shown).
3.2. CD98 stimulation by anti-CD98 mAb activates
CEA-CAM-1-mediated cell adhesion
Cell adhesion independent of Ca2þ is a typical feature of
the adhesion molecules of the immunoglobulin superfamily
(ISF). As shown in Fig. 2A, F9 cells expressed signi¢cant
CEA-CAM-1, a member of the ISF, while EL cells did so
only marginally. While CEA-CAM-1 was expressed around
the entire cell surface of control F9 cells, it was localized at
the contact sites of packed F9 cells cultured with mAb 14.37
(Fig. 2B, a vs. b). We then examined the e¡ect of a blocking
anti-CEA-CAM-1 antibody (#231) on the clumping of F9
cells. Inclusion of antibody #231 up to a ¢nal 1:100 dilution
either preceding or together with mAb 14.37 in the culture,
however, did not a¡ect the clumping of F9 cells at 24 h. The
development of cell clumping became microscopically evident
Fig. 1. Anti-CD98 mAb induces Ca2þ-independent cell clumping of F9 cells. F9 cells were cultured in the absence (a,c,e) or presence (b,d,f) of
mAb 14.37 (2 Wg/ml) for 24 h. a,b: Phase-contrast pictures (original magni¢cation, U200). c,d: Immunostaining with biotinylated mAb 10.10
and rhodamine^streptavidin (original magni¢cation, U600). e,f : Phase-contrast pictures after treatment with trypsin/EDTA for 5 min. Arrow-
heads indicate the cell contact-free surface.
Fig. 2. Expression of CEA-CAM-1 in F9 cells. A: Flow cytometric analysis of CEA-CAM-1 in EL and F9 cells. B: F9 cells cultured in the ab-
sence (a) or presence (b) of mAb 14.37 for 24 h were immunostained with anti-CEA-CAM-1 antibody. Merged pictures with Nomarski are
shown. Arrowheads indicate the cell contact-free surface.
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only after 24 h, and it was possible that turnover of cell sur-
face CEA-CAM-1 occurred during the period. We therefore
intended to examine the e¡ect of CD98 stimulation on CEA-
CAM-1-activation more directly by establishing BaF/3 cells
stably expressing CEA-CAM-1 (B/C-CAM-1) of either the
long (L) or the short (S) isoform (Fig. 3A). Neither B/C-
CAM-1L nor B/C-CAM-1S was aggregated spontaneously
(data not shown). However, both cell lines, but not the pa-
rental BaF/3 line, showed marked cell aggregation within as
early as 1 h after the addition of mAb 14.37 (Fig. 3B, a^c).
This rapid aggregation was inhibited completely by the inclu-
sion of antibody #231 at a ¢nal dilution of 1:200 (Fig. 3B, d),
while the preimmune serum was without e¡ect (data not
shown).
3.3. Association of CD98 with CEA-CAM-1
We then examined the possible association of CD98 with
CEA-CAM-1. F9 cells were lysed with bu¡er containing vary-
ing concentrations of NP-40. As shown in Fig. 4A, a signi¢-
cant proportion of CEA-CAM-1 was co-immunoprecipitated
by mAb 10.10 at 0.1% NP-40, while the e⁄ciency was reduced
at higher NP-40 concentrations. The extent of co-immunopre-
cipitation was enhanced when F9 cells were cultured in the
presence of mAb 14.37. Similarly, CEA-CAM-1 was co-im-
munoprecipitated in B/C-CAM-1L cells by either anti-CD98-
H (10.10) or anti-CD98-L mAb (10.7) (Fig. 4A), indicating
that a portion of CEA-CAM-1 was associated with heterodi-
meric CD98 complex. To con¢rm the results, F9 and B/C-
CAM-1L cells cultured in the presence of mAb 14.37 were
two-color-stained with mAb 10.10 and anti-CEA-CAM-1
antibody. As shown in Fig. 4B, CD98 and CEA-CAM-1
were co-localized at the cell adhesion sites in both cell types.
3.4. Probable involvement of PKCN in the activation of
CEA-CAM-1-mediated cell adhesion by anti-CD98 mAb
Among a number of metabolic inhibitors examined, rottler-
in, a speci¢c inhibitor of PKCN, completely inhibited the ag-
gregation of B/C-CAM-1L cells by mAb 14.37 (Fig. 5A). The
inhibitory e¡ect was speci¢c for CEA-CAM-1-mediated cell
aggregation, because the same dose of rottlerin did not a¡ect
the LFA-1-mediated aggregation of B/LFA-1 cells by mAb
14.37 (Fig. 5A). In contrast, a PI3K inhibitor, wortmannin,
which inhibited the aggregation of B/LFA-1 cells, hardly af-
fected the aggregation of B/C-CAM-1L cells (Fig. 5A). Tryp-
sin/EDTA-resistant aggregation of F9 cells cultured with mAb
14.37 for 24 h was also inhibited by rottlerin (Fig. 5A). Cy-
tochalasin D inhibited the aggregation of both cell types (data
not shown). Immunostaining analysis revealed that endoge-
nous PKCN, which was present di¡usely in the cytoplasm of
control F9 cells, was translocated to the cell adhesion sites 5 h
after the culture with mAb 14.37 (Fig. 5B). In the additional
presence of rottlerin, this translocation of PKCN was inhibited
signi¢cantly (Fig. 5C). Concomitantly, shrinkage in the cell
size of F9 cells cultured in the presence of mAb 14.37 was
inhibited by rottlerin (Fig. 5B), suggesting that the PKCN
translocation played a critical role in the cell clumping of
F9 cells by anti-CD98 mAb.
4. Discussion
While CEA-CAM-1 mediates homophilic cell adhesion, the
precise mechanisms for its regulation remain largely un-
known. The present results demonstrated that anti-CD98
mAbs induced rapid cell aggregation in the BaF3 cell lines
expressing CEA-CAM-1, but not in the parental BaF3 cells
with little endogenous CEA-CAM-1, and the aggregation was
blocked by anti-CEA-CAM-1 antibody. A similar e¡ect was
observed when using two anti-CD98 H mAbs with di¡erent
epitope speci¢city, implying that the e¡ect was due to the
cross-linkage of CD98 antigen. A signi¢cant portion of
CEA-CAM-1 could be co-immunoprecipitated by anti-CD98
mAb, although it remained to be seen whether they were
associated directly or just coexisted in the same membrane
domain. Consistent with this, CEA-CAM-1 and CD98 were
co-localized at the cell adhesion sites in the B/C-CAM-1 cells
stimulated by anti-CD98 mAb. These results indicate that
CD98 stimulation could activate the cell adhesion mediated
by CEA-CAM-1.
The aggregation of B/C-CAM-1 cells by anti-CD98 mAb
was inhibited speci¢cally by rottlerin, an inhibitor of PKCN.
Rottlerin has been reported to be fairly speci¢c for PKCN [17],
which is a member of the novel PKCs activated by diacylgly-
cerol independently of Ca2þ and translocated to membranes
in response to phorbol esters [18]. Among a number of sug-
gested functions, recent reports indicated the involvement of
Fig. 3. Anti-CD98 mAb activates CEA-CAM-1-mediated cell adhe-
sion. A: Expression of CEA-CAM-1 in BaF/3 cells transfected with
cDNA of CEA-CAM-1S or CEA-CAM-1L. B: Parental BaF/3 (a),
B/C-CAM-1S (b) or B/C-CAM-1L (c,d) cells were cultured in the
presence of mAb 14.37 alone (a^c) or together with a blocking anti-
CEA-CAM-1 antibody (d).
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PKCN in the control of cell adhesion. For instance, PKCN was
shown to regulate E-cadherin-mediated cell adhesion by inter-
acting with DF3/MUC1 [19] or RACK1 sca¡olding protein
[20]. It was also reported that the aggregation of U937 cells by
anti-CD98 mAb was inhibited signi¢cantly by rottlerin,
although adhesion molecules involved in the aggregation re-
mained to be determined [21]. On the other hand, we reported
that anti-CD98 mAb activated LFA-1/ICAM-1-mediated ad-
hesion via PI3K and Rap1 activation in an LFA-1-dependent
manner [12], and recently it was indicated that PI3K activa-
tion by cross-linking CD98 was dependent on integrins [13].
Activation of CEA-CAM-1-mediated adhesion by anti-CD98
mAb, however, was una¡ected by a PI3K inhibitor. In con-
trast, activation of LFA-1-mediated cell adhesion by the same
mAb was not a¡ected by rottlerin. Thus, the present results
strongly suggested that CD98 stimulation could activate
CEA-CAM-1-mediated cell adhesion via PKCN independently
of integrins.
In F9 cells that endogenously expressed signi¢cant CEA-
CAM-1, anti-CD98 mAbs induced compact cell clumping
reminiscent of embryonic bodies after 24 h in the culture.
Anti-CD98 mAb induced the translocation of PKCN to the
cell adhesion sites in F9 cells, and rottlerin that inhibited this
translocation suppressed the cell clumping, strongly suggest-
ing the critical role of PKCN activation. An attempt to block
the F9 cell clumping by anti-CEA-CAM-1 antibody was with-
out success. However, even B/C-CAM-1 cells developed sig-
ni¢cant cell aggregation in the presence of both mAb 14.37
and anti-CEA-CAM-1 antibody, when they were cultured for
as long as 24 h (Kakugawa et al., unpublished data). The
results implied that membrane turnover of active CEA-
CAM-1 overcame the blocking e¡ect of the antibody. Thus,
it is likely that CD98 stimulation activates the endogenous
CEA-CAM-1 in F9 cells via PKCN leading to the character-
istic cell clumping, although additional e¡ects of CD98 stim-
ulation on other adhesion systems including E-cadherin and
integrins remain to be investigated.
CEA-CAMs are multifunctional proteins involved in not
only cell adhesion but also inhibition of tumor growth
[22,23]. Interestingly, CD98 stimulation has also been re-
ported to inhibit the growth of certain tumor cells [24]. Our
unpublished results indicated that the growth of F9 cells that
expressed both L and S isoforms of CEA-CAM-1 was inhib-
ited in the presence of mAb 14.37, while that of B/C-CAM-1L
or B/C-CAM-1S was una¡ected (Kakugawa et al., unpub-
lished). Growth inhibition mediated by CEA-CAM-1 was
shown to require the expression of both L and S forms at
certain ratios [25], and thus it may be an intriguing possibility
Fig. 4. Co-immunoprecipitation and co-localization of CEA-CAM-1 and CD98. A: (left) F9 cells cultured with or without mAb 14.37 were
lysed with bu¡er containing varying concentrations of NP-40, immunoprecipitated with mAb 10.10, and immunoblotted with anti-CEA-CAM-1
antibody. (right) B/CAM-1S cells were lysed (0.1% NP-40), immunoprecipitated with control IgG, mAb 10.10, or 10.7 (anti-CD98-L chain) fol-
lowed by immunoblotting with the indicated antibodies. B: F9 and B/C-CAM-1L cells were cultured in the presence of mAb 14.37 for 24 and
2 h respectively, and two-color-stained with mAb 10.10 (red) and anti-CEA-CAM-1 antibody (green).
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that CD98 stimulation inhibits tumor cell growth in part
through CEA-CAM-1 activation. CEA-CAMs are suggested
to play signi¢cant roles in the control of tumor growth and
invasion, and CD98 may provide a unique molecular target to
control malignancy.
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Fig. 5. Inhibition of the cell aggregation and translocation of PKCN
by rottlerin. A: B/C-CAM-1 and B/LFA-1 cells were cultured with
mAb 14.37 in the absence or presence of rottlerin (5 WM) or wort-
mannin (50 nM) for 2 h. F9 cells were cultured in the presence of
mAb 14.37 for 24 h with or without rottlerin (5 WM), and treated
with trypsin/EDTA. B: F9 cells were cultured in the absence or
presence of mAb 14.37 for 5 h with or without rottlerin, and immu-
nostained with anti-PKCN antibody (original magni¢cation, U600).
Note the di¡erence in cell size among the three groups.
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